Antibody promises more accurate smear tests:
This article was originally published in Clinica
Executive Summary
An antibody that reacts strongly with cancer marker proteins in cervical tissue could be the basis for a more accurate and cost-effective Pap smear test, says Matritech after a US pre-clinical study of its NMP-179 antibody. It has granted Bayer rights to develop automated screening tests using the antibody.